Relacorilant NDA updates -- FDA PDUFA date set for Dec. 30, 2025 (hypercortisolism); platinum-resistant ovarian cancer PDUFA ...
Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to its high mortality. This ...
Breast cancer remains a predominant global health challenge for women, with late-stage diagnosis being a key contributor to ...
Blood tests are a simple and practical tool for understanding your health and guiding your care. Different types of blood ...